Clinical Trial to Investigate the Efficacy and Safety of LN-OS-22 on Oxidative Stress and Systemic Inflammation in Overweight and Obese Population.

NCT05404217 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Oxidative Stress

Interventions

OTHER: LN-OS-22
OTHER: Maltodextrin

Sponsor

Vedic Lifesciences Pvt. Ltd.